Inhibitory effects of opioids on voltage-dependent Ca(2+) channels and catecholamine secretion in cultured porcine adrenal chromaffin cells

Brain Res. 2002 Jun 28;942(1-2):11-22. doi: 10.1016/s0006-8993(02)02648-3.

Abstract

The inhibitory effects of opioids on voltage-dependent calcium channels (VDCCs) were investigated in cultured porcine adrenal chromaffin cells using whole-cell patch clamp technique. The effects of the opioid on [Ca(2+)](i) increase and catecholamine secretion induced by high K(+) were also examined in single cells by fura-2 microfluorimetry and amperometry. A depolarizing pulse to 0 mV (test pulse) from a holding potential of -80 mV evoked an inward barium current (I(Ba)), which was reversibly inhibited by methionine-enkephalin. This inhibitory effect of methionine-enkephalin was abolished by naloxone. Selective agonists of opioid receptor subtypes (DAMGO: mu, DPDPE: delta, U50488: kappa) dose-dependently inhibited I(Ba). In inhibitory potency, the order was DAMGO>U50488>DPDPE. These agonists applied sequentially produced a reversible I(Ba) inhibition in the same cells. The inhibitory effect of DAMGO on I(Ba) almost disappeared in the presence of omega-conotoxin GVIA but not omega-agatoxin IVA plus nifedipine. Application of a conditioning prepulse to +100 mV prior to the test pulse partly retrieved the I(Ba) inhibition by DAMGO, suggesting the involvement of voltage-sensitive components in opioid-induced VDCC inhibition. Intracellular application of GDPbetaS or GTPgammaS as well as pretreatment with pertussis toxin significantly reduced the extent of I(Ba) inhibition induced by DAMGO. DAMGO reversibly inhibited the [Ca(2+)](i) increase and catecholamine release induced by high K(+). RT-PCR revealed the expression of mu-, delta- and kappa-opioid receptor mRNAs in cultured adrenal chromaffin cells. These results suggest that porcine adrenal chromaffin cells possess mu-, delta- and kappa-opioid receptors and activation of opioid receptors mainly inhibits N-type VDCCs via pertussis toxin-sensitive G-proteins.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer / pharmacology
  • Adrenal Medulla / drug effects
  • Adrenal Medulla / metabolism*
  • Animals
  • Barium / pharmacology
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels / drug effects
  • Calcium Channels / metabolism*
  • Calcium Channels, N-Type / drug effects
  • Calcium Channels, N-Type / metabolism
  • Calcium Signaling / drug effects
  • Calcium Signaling / physiology
  • Catecholamines / metabolism*
  • Chromaffin Cells / drug effects
  • Chromaffin Cells / metabolism*
  • Dose-Response Relationship, Drug
  • Electric Stimulation
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)- / pharmacology
  • Enkephalin, D-Penicillamine (2,5)- / pharmacology
  • Enkephalin, Methionine / metabolism
  • Enkephalin, Methionine / pharmacology
  • GTP-Binding Proteins / drug effects
  • GTP-Binding Proteins / metabolism
  • Guanosine 5'-O-(3-Thiotriphosphate) / pharmacology
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Narcotics / metabolism*
  • Narcotics / pharmacology
  • Neural Inhibition / drug effects
  • Neural Inhibition / physiology*
  • Potassium Chloride / pharmacology
  • RNA, Messenger / drug effects
  • RNA, Messenger / metabolism
  • Receptors, Opioid / drug effects
  • Receptors, Opioid / genetics
  • Receptors, Opioid / metabolism*
  • Swine

Substances

  • Calcium Channel Blockers
  • Calcium Channels
  • Calcium Channels, N-Type
  • Catecholamines
  • Narcotics
  • RNA, Messenger
  • Receptors, Opioid
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
  • Barium
  • Guanosine 5'-O-(3-Thiotriphosphate)
  • Enkephalin, Methionine
  • Potassium Chloride
  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
  • Enkephalin, D-Penicillamine (2,5)-
  • GTP-Binding Proteins